Moderna (MRNA) Tops Q2 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Moderna Reports Second Quarter 2020 Financial Results and Provides Business Updates
August 5, 2020 7:00 AM EDTEnded quarter with $3.1 billion in cash, cash equivalents and investments
Moderna has received approximately $400 million of customer deposits as of July 31, 2020 for potential supply of mRNA-1273
Moderna updates 2020 guidance to reflect investments into mRNA-1273; the Company now expects net cash used in operating activities and for purchases of property and equipment to be between $0.65 to $0.85 billion, including the benefit of customer deposits received as of July 31, 2020
Phase 3 study of mRNA-1273 being conducted in collaboration with NIH and BARDA on track to complete... More
